Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9UVzRxZWUyc3FWVU0yZ25XOV9JYWduVkFvU3FuRzh4MHRSNFVmRUtESTdKVnNnLVB6VVNGTUxoWTB3a1dQMmlwYjBEQTBCMURLdHFEdF9ieHI2bi1KVFBLemFBUWNsNW5IY1dyY2tn0gFyQVVfeXFMTkNDeEx6WGFYaHdtSFBrb2RqX0VVaEdzRUV6WXNFUVkxQmxabUNETzlDLXFiYW1WdTJocHRXOGRTTUJJTHNMQmtlZXVLOUc5cVkyd0ZVMHFIWnUwZzFxal9hNTVlWVdQaTNtZ1hfRmRUOUZR?oc=5" target="_blank">Samsung Biologics clears takeover threshold as 87.88% of PolyPeptide shares tendered</a>&nbsp;&nbsp;<font color="#6f6f6f">Korea Biomedical Review</font>
"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
OpenAI engineer arrested in bugging of executive conference room
The Myth of St. Francis
Bayern’s Michael Olise sent off for 2 yellow cards within seconds in Champions League
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE1PN1dhVmJNclF3dW04Xzd3S2h5Y3dnX2VJMVZHMGxoWTJieVFfS1REMUlsYzh3Wmc3UUh1S0dFQm9UNUNSYnZEWFBFWm54dEM1UDhraDFlckIxSGV4S1NMakY5bUQ1WFZWZy05c0ZWaVpkSWd0?oc=5" target="_blank">Samsung Biologics Secures 87.8% Stake in Polypeptide</a>&nbsp;&nbsp;<font color="#6f6f6f">Businesskorea</font>
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxQOVVmR08xY1NaM0t3ZGsxR0V6WkpmSWE3U0NKNm42UVlodWkzYzBEdFhpaHZOVndkOFBMcFY5bHRUMDBJVTJHOVJHWGhMSlozcnM4QVY5SmZfSU5MTzExMWl6WjJlOVRYN1pCVkpRNG9QZDM1WXZMbTBYZktTa3g0TUJ2bnZfLXpUU0E5aGt1ZHVGS0XSAZgBQVVfeXFMT1B3U3JnNXBkMy1NM3I5X1ZlSHBFR1I3Z1NoRmJGSWpla0E2cXlWRlFQUEUwOVh0V09uUEtNLTRDazkwMHRNREpkYUNWZTl1OHdpaVZWeGVZWTRDOVNkTnliTXc0MVoyNVFOVkk4VEdUWEltcldRekVRZ2M2bFZxT1F0bmF2WGprdzBFMWwtUVV0M25BMm9nNi0?oc=5" target="_blank">Samsung Biologics makes $1.8 billion all-cash offer for Switzerland's PolyPeptide Group</a>&nbsp;&nbsp;<font color="#6f6f6f">CNBC</font>
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQV3IwNUp2LVFGeDJFQXJmS3JyOVprUnZ6cERjaGdCd1R0MTViMWhGTkY3S01YRzdndllFZUhPbXVKOHdVWGVwMmJ4bFdhb0d5MDRjTHRKbzFMdGlUUHlsRFpRbHFxVGpJOGlxVzFJdUppN0tkLUFmcXR3UEN4RVZ3UkJTMFZwMXI3RW40b2NWMDZnbElkMVFtMk1vWHBaazh3N0FuVUhNVnJvRmlya1ZERVpzY0hlWnpISjBz?oc=5" target="_blank">Samsung Biologics offers to acquire PolyPeptide for $1.8B</a>&nbsp;&nbsp;<font color="#6f6f6f">BioProcess International</font>
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPeVI2OUxXSUJRQUNYZ0VRWXRfV09lQ1o3U3BycW9JbWxkRjA1RHVRZXpzei1wMUNIenF6dTBoSmFTZUtIM1VDSDJUVHVKZ25MTUtGM1ZpTXJIX0lXOUtNUjljYmNVMVVSVXg4RWN1Nnlndk83dE5nMzJDdWhvd3N5cEtUbVFCaDBZOHg4ZV96elRRSHpuOG40LTRqWXhJbkJnZkgzT0NCM3JNQUdDQjFETFU1c3d2SnBnOE9QckVIMXpWZw?oc=5" target="_blank">Samsung Bio, waiting to break into peptides, nets $262M manufacturing deal with unnamed EU pharma</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Pharma</font>
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxPWnRaemp1WHU4YmZzbGh5enNPMlFHUXluN0VOT1JnNVUwam5yNGpkNXNleFpqQnprSHZLWWpiYmxNaG96Y29icmNteTNZdnhWSTBWN3BXXzEyVmxQbmZVNE5qdVpuY1dmbDQyOHc5NXlNQ3JEYzJrN05yYkhJalZXZ2JFajJtQmsyY3BVNzlCRmw2RllEY3hONFF2QjlmWDBmRXgzMVJuVEJRNXl1Wjl0SWd2OHRSTE9iTERIcnZnZkhpRzh3UDEzZEtR?oc=5" target="_blank">Samsung Biologics publishes prospectus for PolyPeptide public tender offer</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQM01ucWRqWnpRZ1hCSjBseUpDT1BCR3d4TDE2eU9YYXhfekYxY2lFZWFtbDBJd0NlWXA0Y0tCS1A0MzU4ZTFtbkJBV2ltY2JTVEU2VG5mOURIQ3lkaXpScFFHb3c1b1R1TTlCa1NLTV9yR09ucjJoOExsMUJuZFJpeDJsc1FlVm90RWxXcmJlZXhPaW9qZGxzdXA2NjM?oc=5" target="_blank">Peptides are big, and Samsung Biologics is paying $1.8 billion to get in on the action</a>&nbsp;&nbsp;<font color="#6f6f6f">Chemical & Engineering News</font>
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZTRDRWZtUFh1ZUZ4QnVGZ1o0RkFQamI4QkdZNnZBVDVITnRYZzlxdWVlQmVjdk1JZDEzRWZOTVg3YVFfVnd6Nm1oYVRsX0otVWQyV0pQek5zRk1MM2tZT0lNVVNfOF9jVk4wU0VYT2I4Smt4N1ZPQlRZcGZJY09DS3lvR1hBMUJzRFVuRXBmSTNlc0dabzVFbTB0WXBHT3h5SVE0cnNqb2dYdw?oc=5" target="_blank">Samsung Biologics makes bold peptide play with $1.8bn PolyPeptide buy</a>&nbsp;&nbsp;<font color="#6f6f6f">BioXconomy</font>
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE52NDd5Ny0xOXBEbDBjdHVxY2VGbGZoQ29wN0ZhbUYxMi1rVEt3bjdDVWVpbnBsdmwxQzFMZUUtVHdpUjlyNjZXRWMyWTlVMkVmY3RQUTREdw?oc=5" target="_blank">Samsung Biologics showcases faster drug development at Boston conference</a>&nbsp;&nbsp;<font color="#6f6f6f">The Korea Herald</font>
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQYUZKV2NDUkh1WWhGeHhudjZxZnhYdGpwQ3Y4X2p1eG5tTGpFbDFyS0JaNzhTSGh3UmFTdWo1VTNlVjY4UW9qa1E2ZmRQamFQQThLZURNNlR4OTdEaVR4UDFfMGRNUDNMQmluVTlNTzZ0RlktdlJFRE5RT0x1U2dWVi1FWkZqRnFPZ3M5aHk4Y0JzX2NPMkZzSkJ5OXpQYW9SRlFDQWFEMlhCTjZBN1QxdzRtc2Y?oc=5" target="_blank">Samsung Biologics to Buy PolyPeptide in $1.8 Billion Deal</a>&nbsp;&nbsp;<font color="#6f6f6f">Bloomberg.com</font>
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQMXBrN1RISWg5bFd5MjFua2dHT19HTDlwOFFWbWNyRUUtWDRyclVkS19OOFVodFJxc1o4dTdDN0lNX214SW9RWWpGby1IdHJsRDAtb24yajg5UkdGclFXLXBMa2FoSVFMVDNseDIxRWdtUVF2c2pYeEgxeXlGNWpocG1hVXpWTzk0YzQ4SDBDUkthNVFaaGpFazB6aFpEWUlHdXlPUWJSaw?oc=5" target="_blank">Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQV2VDLWJwVTFXdURQeExZaWNnV2EyTnRwYllQNmlyZVlIN3MtWXh2Ri1iT2V3c0VmTGc3NWFlS0laUjk1WE9PdE9yemV2Tk95UVZpVWhyZU5rY3JVenNJRmxXNjAweDNDTVd6Vm1VUUs1bjRlSnhKNnRyUXJMUUNxSUVZdU1ZYWYyZ1hPSkJMZzZ2aGsyS1ZXbThpM0pQZXFxTGNmQkpEd0dEcTNTbnZmTlh5QVJmcTFvR0tzcXdhcw?oc=5" target="_blank">Samsung Biologics expands into the United States: Acquisition of Rockville biologics manufacturing facility</a>&nbsp;&nbsp;<font color="#6f6f6f">samsung.com</font>
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNZ1FzbmtIUVJEYk52bTRCQVlaRE8xR3RZWVNsbXBBemZQYW5hTDhraVU2S2tJVWtJV0FrcTlQUGVQalU1ZG5KY2Q4aGZ5aW1FaW01RW5HM2JEVEJBRGxoRFBOY19Ha1VELTdtSjBLTzdHZGgweVdIZDNod29nMUZ3bzd1TlpRRFkz?oc=5" target="_blank">Samsung Biologics agrees $1.81bn takeover of PolyPeptide</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmaphorum</font>
<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxOSHEtdC1VUVdYWjBISk14TGxUVXBZbjB0RS05elBOWWdVR0R1RkhMdjRtTDJxQk9xNDNQeGViYzRTQ3NVSFE0T2c0YmEyb2ZKc1lnUGhzd3J6REVJOEMxdC0yZEFQWkFjOUtMb2QzMTk0c3d3OHpncGdjOVV3ZTB1WDJRWlRhUTFNSTBqMHRubE44S3lLc2dZZG9rbmdubWVvcmJPWkJjOW93OHl0OWUtUHk0aU9MZ0hweTd3OFJ3N25VbGhxUXE3Vk5ZT0NVcG5pdWF0T3NMSjZBR2w4dk43Wm1tS1pBeGpZSlpiNmI4NkhrWW56a1VKR2hPU00?oc=5" target="_blank">PolyPeptide Group: Samsung Biologics announces tender offer to acquire PolyPeptide Group AG for CHF 44.31 per share</a>&nbsp;&nbsp;<font color="#6f6f6f">TradingView</font>
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNY2IwM2hUV1U2dlBPeW5jX0UwbmJTYnFEZnpYbUxBeWVKS1BuWUlPN2V1bV9NQXkzaWVlUTdyM0FJQ2lrWFd2TGVuUE9rQ2ZVSTJQNzdPLXdPOTcyQVM1Sl9ZUnJ3NFlkMnlJSG1uQVJxWVRvUkJidER0dXJBMUU4NktmRzVQNjNJSUM3NmlZR1pQd0p1bzJ1SHdXYlJnZ3gwSXVtWGlwSThJUGx2RlROY3I0RU4zYUpaQm1tLXY5OE1leldab2pjWEw3YlU?oc=5" target="_blank">Samsung Biologics set for largest Korean pharma M&A with $1.8B PolyPeptide deal</a>&nbsp;&nbsp;<font color="#6f6f6f">Korea JoongAng Daily</font>
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOX0NPbmJMemRhZE1lZkJWQlhTWmNRa3JzMnNzQzZtN3FnSDA3T3k3MlZWaU1XRnpLb0o1MFRsc0ZKakhoakZfbW9Ncno3OVBOR0E5S2UxMjdhMDJDcHI4Zkdsb3ZfbnlqOUgxVVRMZzl0VmQ4cXRWdjFrMHlOWExaYWVqQjNVcnlF?oc=5" target="_blank">Samsung Biologics Union Demands Negotiations With Samsung Electronics</a>&nbsp;&nbsp;<font color="#6f6f6f">조선일보</font>
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE9rRXJxYTRfdW1lcEpoYkFXWEpxRXBWTTE0Z3RVbG41aWpsWXpFUTBlTk1Za0lIVkEtaU84RHFEME1oZ0FTRHNyRm5NSi16eXZNWlJNMERCbEt1Y1dEWmNfLTFTNW1iMUhUdkNYbGFB0gFyQVVfeXFMTWxDaFMyNnBId2YtbWJfcG1FNEdaZVAwUG9hS25MU2FKbEw2U1Z4WnZCNldMemlyRUFmQlViLXdla1pkQ3ZmSFV3TkxVa3N6SGNqZ2l4dHprWUxXdXhXeDJMVDJzQzdtZldITUFUNUhCNE13?oc=5" target="_blank">Samsung Biologics pitches end-to-end CDMO services as Japan demand surges</a>&nbsp;&nbsp;<font color="#6f6f6f">Korea Biomedical Review</font>
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZmF5U2Y1S3JnUHlQX1oxT25iYlNyaW5RTFRwRnhZWUlmQUhwems3bnlZZWhqdGFiMFdWa3lHY1M5X3hZdk1uaG9zcjRlMEtDVnhlaFFPZVFZMUNoYmpQdV9jMXgyLTkzLTQ3MW44amV6elhHZVpJVk1xeWhKMjlyYURVTURMdjNiSG53Rm9uaVNwQlhGa1dvbjJyYm85NnpOTzBCWnZNT2VzWjQ5ODhvT3V0UWFJR3hHZU9Z?oc=5" target="_blank">Samsung Biologics Reports Second Quarter 2026 Financial Results</a>&nbsp;&nbsp;<font color="#6f6f6f">PR Newswire</font>
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRXNfNjg5V3gyLXg3eDVJSnJNVVlBLXhaTjduQmlVUXVHQVhYWE54WTdtOTVGQldrcHZMaWVJOHhLQmtqajhEd0FpTDlkRUdhaVd2bVhtbU5XV3E2WXY5QTIzQjZva3h4LWVkc2pyM3dJRkpkd2g2R1cxbHYtTXlVUWZ3OUpsWUcySVlOSjBoaGZiaWJxbW1XOTdXZWtrZzRTbFgwdVNSTnpyRDV2VU5tSV9qRUJuZU9WdzFYbHc1Z0w5UQ?oc=5" target="_blank">Samsung Biologics union tests parent’s employer role, 'Yellow Envelope' act</a>&nbsp;&nbsp;<font color="#6f6f6f">Korea JoongAng Daily</font>
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE82VUhzLXNBa05PUHVSQUdGeVlHZF82cEVCcTdwcmxYSG5ocndSMGFhY0tmMFQ3VUJLV2pjckRYdHdObkVxYzlkS0dYLXFqVE1xWG1SQ1JJdlhLMHFVcXJ5Zy1aSVpiWjEzQWlRUU1n0gFyQVVfeXFMT0hENlBhUXF0OF9mTm1pR0d2YUNIYmhtOFNBUkZiRUk3UDlUdXRrQUtOTXhneDFiZUE3YmVPMkVVZnZqa3lqb3FPbUd2dTZKMXZwNFlPY3dPR3o1ZS1mSzV6elQweGdTYmVxSzVzTXpBS0p3?oc=5" target="_blank">Samsung Biologics takes ADC, next-generation CDMO push to 4 global industry events</a>&nbsp;&nbsp;<font color="#6f6f6f">Korea Biomedical Review</font>
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1MNkwyaHBrR3gwWVktZXNYSGpTdzVNdVN6dlpTZGI2SE1EWldJX0R3aGYyQ1M5N2VNbGtKSzhKNHhxZDdCYS11SEliYVozZTVpYXBpVVgtTnliaVZvNDhUSDY1Y1BCNkp2X1NxNVJ30gFyQVVfeXFMT3c0UWlvdjdwT2hHRV9TdTc4ZGdZWnFtbU83Q2wzZGJiVzV5eTUwbzBxRTR0N0JqVHlBVU11ek5CeGplSnI4NXRqRWFCNnhrbXh2VFFuOXYtS3RxYTA2UXpkWFN1ZjdvbkpTdm5hUmd5RU5R?oc=5" target="_blank">Samsung Biologics discloses $261 mil. contract manufacturing agreement</a>&nbsp;&nbsp;<font color="#6f6f6f">Korea Biomedical Review</font>
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9WNV9PWTlrTmthcF9GYmJ6ZWJzNVREMk0zMUdXOG9HUHgwamxBUHBPRXRhTVhHTWJKVDlYWXdiam1pM2ZtendoSDNsTUxXNHh5T1h2elVqd1M5alRXcTJ6WUxHQTVUODc0M3hwTndYYThwbGd6TEE?oc=5" target="_blank">Samsung Biologics, SK Biopharm, Hanmi Pharmaceutical Land in APAC Bio "Top 10 Deals"</a>&nbsp;&nbsp;<font color="#6f6f6f">BigGo Finance</font>
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOQWlaVzNlUlkyM0tjQzRqSlgydGdRbl9QSzJ2X3o5N3E4Q2dpeXUtakQ2Y01kUU0yTzhETWgwVlNocmY0MDZWc01MY2VFWXlxb1ZvWXAzZnBnUjhKNEk3UjhNMjQ2dGdfdUVsLWxmMDR2bzdvMzVGWVdKT3dUZTloVDFmTlpYa05KU1lhZQ?oc=5" target="_blank">Eyes on Asia: Axiom, Pathos AI, Samsung Biologics</a>&nbsp;&nbsp;<font color="#6f6f6f">BioXconomy</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQQ3pQc0RfcGVRMEJRMnFoRWkzMkVZMl9wRjlBa0ZWRTRhS08wMGY3SW82WHpRMm1La08zUU9vbldVRkVHeWdBdUZzcU5HS0dZa0NyWWVHZmRmMjM3QzJIeGFUb25xYVRkSU11MWdrYXc2bHhCZ056ME1TNDVSRF80OUV2UllmMWwwZTFELUFnd1RCN3hTQmZqOHU2TQ?oc=5" target="_blank">Samsung Biologics Positions Itself as Key Partner for Blockbuster Drugs</a>&nbsp;&nbsp;<font color="#6f6f6f">Seoul Economic Daily</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOeDZBR1oxZl9SeS1DbE5RcGhJem04RExQY0s5UGE1LVVyRDlIYWMtSjB6a2lDUWdmeVZkcEdNQWRDVWxLQmVBbjJ0WEp5allGcW5oTFFVMldYYm9LWnpnd3lSdVJCdkFyN09HTUFfcEtJdGswd1ZOMWE3X1VZN181Nnk4UDhNb1ItaTFHeTJTMVRFNVJIa2YxMnRGVF9jeXF1VE4wOTVB?oc=5" target="_blank">Samsung Biologics, SK Biopharm, Hanmi Make Asia-Pacific's Top 10 Biotech Deals</a>&nbsp;&nbsp;<font color="#6f6f6f">Seoul Economic Daily</font>
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9SbWI0dzdUdEVlanh1MDRoWFpQN2YySHZTU0hJSkxCbUdxUkxnRFlNU3M0MXZMNFU2Zlg1YUtpY2FySGktTVFkc0RFeUhNYTl4SldPeHJnVmVrdGRLTzF6eW9Rb3NYYVY1TGhqYm1NVWdjcTdfRlE?oc=5" target="_blank">Samsung Biologics Acquires Swiss CDMO for approximately $1.8 Billion, Making a Major Push into the Obesity Drug Market</a>&nbsp;&nbsp;<font color="#6f6f6f">BigGo Finance</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3pKeEhzazdxWTFmRm9fVDBWcEZyZ25RekNWN1lHVU1maC1YNUY5MjdJRk40MXd3RzJFQTVrTjFZRlEtS09ld1lWdGpaNFdBUjRKbldtVzNNQmhJSWJ1TEhyVXdjV3Bydk5wVkFmZ1ZKLUlYTm11Y0lNbzJvU2dJb2NwZkpaNzc0eEZnZnpnWnZCYnU2UUN0UFdRR093RUdFb2Q3SGU5RHVpQlp6MFVz?oc=5" target="_blank">Samsung Biologics Launches CHF 1.46B PolyPeptide Tender Offer</a>&nbsp;&nbsp;<font color="#6f6f6f">ChemAnalyst</font>
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE5yNmg3c1JvWmlGR3FqN2hma1RuMnRocDFDZ3FCV2k1NDhaXzVQSGNYODFpb3dpUHp3TXNQZE1wSm1kODFsS29rdFlwYUItRUxhVHBFOXVXWQ?oc=5" target="_blank">Samsung Biologics union votes to leave Samsung-wide labor body</a>&nbsp;&nbsp;<font color="#6f6f6f">The Korea Herald</font>
<a href="https://news.google.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?oc=5" target="_blank">Samsung Biologics to acquire PolyPeptide in $1.8 billion deal</a>&nbsp;&nbsp;<font color="#6f6f6f">Business Standard</font>
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQT3lvckJvbWVzWDBSRTFWT20za25hSE5KSnViWGVZdlFsbEtIS2Z1WXZNb1ZsMlc1ckl6dkxRQnJzX0JtVmRBVXNSc2trYUZUM083V0lPaUx5LUZmTE9CT2x2Q21kSk55QmVuNHUzNmJWZlRpTjl0b3RRLXBROXJ1Ung2OGVBRXM0UWYwcQ?oc=5" target="_blank">Samsung Biologics Moves To Buy PolyPeptide In Cash Deal</a>&nbsp;&nbsp;<font color="#6f6f6f">Finimize</font>